A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to estimate the exposure to the hormones norelgestromin,
norgestrel, and ethinyl estradiol in the bloodstream of healthy female volunteers across
multiple commercial lots of ORTHO EVRA® (a transdermal contraceptive patch) and to compare
these data to historical hormonal exposure data from one ORTHO EVRA® clinical development
lot.
Phase:
Phase 1
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.